Xiaoyan Shi Selected Research

Xiaoyan Shi Research Topics

Disease

37	Neoplasms (Cancer) 01/2024 - 04/2004
10	Neoplasm Metastasis (Metastasis) 12/2022 - 07/2004
10	Breast Neoplasms (Breast Cancer) 11/2022 - 07/2004
6	Atherosclerosis 02/2024 - 01/2021
6	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 07/2007
5	Hepatocellular Carcinoma (Hepatoma) 08/2022 - 09/2011
5	Carcinoma (Carcinomatosis) 01/2014 - 07/2004
4	Inflammation (Inflammations) 01/2024 - 01/2020
4	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 01/2013
3	Insulin Resistance 01/2021 - 01/2019
3	Carcinogenesis 12/2018 - 01/2009
3	Lymphoma (Lymphomas) 05/2017 - 10/2010
2	Osteoporosis 02/2024 - 01/2022
2	Infections 01/2024 - 08/2006
2	Poisoning 01/2023 - 10/2021
2	Fatigue 12/2022 - 10/2002
2	Shock 10/2022 - 08/2006
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 06/2013
2	Spontaneous Abortion (Miscarriage) 10/2020 - 10/2013
2	Hypertension (High Blood Pressure) 06/2020 - 08/2018
2	Sarcoma (Soft Tissue Sarcoma) 10/2019 - 08/2019
2	Liver Neoplasms (Liver Cancer) 01/2019 - 05/2017
2	Colonic Neoplasms (Colon Cancer) 12/2018 - 11/2018
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 07/2013 - 09/2009
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2012 - 03/2011
1	Human Influenza (Influenza) 03/2024
1	Anemia 01/2024
1	Epilepsy (Aura) 01/2024
1	Seizures (Absence Seizure) 01/2024
1	Hyperglycemia 01/2023
1	Respiratory Insufficiency (Respiratory Failure) 01/2023
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2023
1	Insulinoma 01/2023
1	Pancreatitis 01/2023

Drug/Important Bio-Agent (IBA)

19	Proteins (Proteins, Gene)FDA Link 01/2023 - 08/2004
7	paeonolIBA 02/2024 - 10/2020
6	MicroRNAs (MicroRNA)IBA 02/2024 - 01/2018
5	CystathionineIBA 01/2021 - 05/2017
4	Insulin (Novolin)FDA Link 01/2023 - 06/2020
4	Messenger RNA (mRNA)IBA 01/2023 - 08/2004
4	Interleukin-12 (IL 12)IBA 01/2009 - 04/2004
3	IronIBA 01/2024 - 11/2022
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 01/2019
3	LyasesIBA 01/2021 - 09/2017
3	Matrix Metalloproteinases (MMPs)IBA 01/2021 - 01/2019
3	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2019
3	Cisplatin (Platino)FDA LinkGeneric 10/2019 - 04/2008
3	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2018 - 11/2009
3	DNA (Deoxyribonucleic Acid)IBA 02/2018 - 08/2002
2	Apolipoproteins E (ApoE)IBA 02/2024 - 01/2022
2	Sirtuin 1IBA 01/2024 - 01/2019
2	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2022
2	3' Untranslated Regions (3' UTR)IBA 12/2022 - 01/2009
2	CurcuminIBA 08/2022 - 06/2013
2	Immunoglobulin G (IgG)IBA 01/2022 - 08/2002
2	LipopolysaccharidesIBA 01/2022 - 08/2006
2	Caspase 3 (Caspase-3)IBA 01/2022 - 05/2017
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2022 - 10/2002
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021 - 06/2020
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 05/2017
2	PaxillinIBA 01/2021 - 08/2019
2	Angiotensin Receptor AntagonistsIBA 01/2021 - 06/2020
2	Uric Acid (Urate)IBA 06/2020 - 01/2020
2	Vitamin E FDA LinkGeneric 01/2020 - 11/2009
2	Peptides (Polypeptides)IBA 01/2019 - 01/2018
2	Small Interfering RNA (siRNA)IBA 12/2018 - 05/2017
2	Histones (Histone)IBA 11/2018 - 08/2002
2	Pyruvate KinaseIBA 04/2017 - 02/2017
2	Tumor Biomarkers (Tumor Markers)IBA 04/2017 - 02/2017
2	IsoenzymesIBA 04/2017 - 02/2017
2	Rituximab (Mabthera)FDA Link 07/2014 - 07/2013
2	Immunoconjugates (Immunoconjugate)IBA 07/2013 - 09/2009
2	Monoclonal AntibodiesIBA 01/2012 - 03/2011
2	dacetuzumabIBA 03/2011 - 10/2010
2	Vascular Endothelial Growth Factor CIBA 03/2008 - 07/2007
2	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 03/2008 - 07/2007
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 03/2008 - 07/2007
2	AutoantibodiesIBA 09/2007 - 08/2002
2	Interferon-gamma (Interferon, gamma)IBA 08/2006 - 08/2004
1	VaccinesIBA 03/2024
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2024
1	Hemoglobins (Hemoglobin)IBA 01/2024
1	Lacosamide FDA Link 01/2024
1	AcidsIBA 10/2023
1	Drinking WaterIBA 10/2023
1	ApoferritinsIBA 01/2023
1	Antineoplastic Agents (Antineoplastics)IBA 01/2023
1	5-iodotubercidinIBA 01/2023
1	Naloxone (Narcan)FDA LinkGeneric 01/2023
1	Oxygen (Dioxygen)IBA 01/2023
1	Ferritins (Ferritin)IBA 01/2023
1	purineIBA 01/2023
1	Sincalide FDA Link 01/2023
1	Radioisotopes (Radionuclides)IBA 01/2023
1	toripalimabIBA 01/2023

Therapy/Procedure

7	Therapeutics 01/2024 - 03/2011
6	Drug Therapy (Chemotherapy) 01/2023 - 01/2005
1	Contraindications 03/2024
1	Aftercare (After-Treatment) 01/2024
1	Cannula 01/2023